Sort by
Refine Your Search
- 
                
                
                , medical laboratory science, occupational therapy, physical therapy, respiratory therapy, and radiologic sciences and therapy. Graduates of these programs are leaders in their fields who use their knowledge 
- 
                
                
                member of the Oncology Research Information Exchange Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant and N01 
- 
                
                
                / Statistical Genetics or closely related program. Required Qualifications Ph.D. degree in bioinformatics, statistical genetics, biostatistics, or a closely aligned quantitative area. Candidate is expected 
- 
                
                
                in the scientific field and accounts for previously unexplained phenomena for new and/or continuing research projects; participate in determining priorities and planning research programs; carry out 
- 
                
                
                scientific mentor in the Department of Neurology; plan, design and execute experiments of considerable scope and complexity in the assigned research lab; collect and analyzes data for research sponsored by 
- 
                
                
                related quantitative field. • Strong data analytic and programming skills in Python and/or R. • Proficiency in Unix/Linux systems. • Excellent writing and communication 
- 
                
                
                . • Strong data analytic and programming skills in Python and/or R. • Proficiency in Unix/Linux systems. • Excellent writing and communication Additional Information: Location: Pelotonia Research Center (1040 
- 
                
                
                ) Founding member of the Oncology Research Information Exchange Network (ORIEN) Robust clinical trials program with active translational therapeutics that include a clinical research unit, Phase 1 U01 grant